Cubist Systematic Strategies’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1.92M	Buy	+121,530	New	+$1.8M	0.03%	1592
2025 Q2	–	Sell	-198,411	Closed	-$2.02M	–	3483
2025 Q1	$2.02M	Buy	198,411 +197,201	+16,298%	+$2.29M	0.03%	1410
2024 Q4	$19.2K	Buy	+1,210	New	+$62.9K	﹤0.01%	2843
2024 Q1	–	Sell	-411	Closed	-$16.3K	–	4134
2023 Q4	$16.3K	Buy	+411	New	+$12.9K	﹤0.01%	3364
2023 Q2	–	Sell	-8,306	Closed	-$355K	–	3953
2023 Q1	$355K	Buy	8,306 +3,844	+86%	+$194K	﹤0.01%	2876
2022 Q4	$214K	Buy	4,462 +4,167	+1,413%	+$195K	﹤0.01%	3546
2022 Q3	$11K	Sell	295 -24,051	-99%	-$834K	﹤0.01%	4282
2022 Q2	$673K	Buy	+24,346	New	+$1.07M	0.01%	2810
2022 Q1	–	Sell	-214	Closed	-$13K	–	3669
2021 Q4	$13K	Sell	214 -4,758	-96%	-$237K	﹤0.01%	3392
2021 Q3	$197K	Buy	+4,972	New	+$177K	﹤0.01%	2590
2021 Q2	–	Sell	-100	Closed	-$6K	–	3000
2021 Q1	$6K	Sell	100 -100	-50%	-$6.34K	﹤0.01%	2787
2020 Q4	$14K	Sell	200 -707	-78%	-$44.6K	﹤0.01%	2511
2020 Q3	$35K	Buy	907 +9	+1%	+$357	﹤0.01%	2385
2020 Q2	$34K	Buy	+898	New	+$27.7K	﹤0.01%	2292